Free Trial

Treace Medical Concepts (TMCI) Insider Trading & Ownership

Treace Medical Concepts logo
$7.98 +0.22 (+2.84%)
(As of 11/20/2024 ET)

Treace Medical Concepts (NASDAQ:TMCI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.43%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$4.21 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get TMCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Treace Medical Concepts stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TMCI Insider Buying and Selling by Quarter

Treace Medical Concepts Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/16/2024John T TreaceCEOBuy50,000$5.31$265,500.00  
8/15/2024James T TreaceDirectorBuy84,000$5.96$500,640.00  
8/14/2024John T TreaceCEOBuy85,000$6.00$510,000.00  
6/11/2024John T TreaceCEOBuy45,000$5.88$264,600.00  
5/31/2024James T TreaceDirectorBuy25,000$6.05$151,250.00  
5/28/2024James T TreaceDirectorBuy50,000$5.07$253,500.00  
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

5/22/2024Richard W MottDirectorBuy12,100$4.99$60,379.00  
5/17/2024John T TreaceCEOBuy100,000$5.56$556,000.00  
5/13/2024John T TreaceCEOBuy150,000$4.56$684,000.00  
5/13/2024Richard W MottDirectorBuy36,802$4.38$161,192.76  
5/10/2024Deepti JainDirectorBuy25,000$4.50$112,500.00  
5/10/2024John T TreaceCEOBuy150,000$4.58$687,000.00  
(Data available from 1/1/2013 forward)

TMCI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Treace Medical Concepts includes Aaron Berutti, Daniel E Owens, Deepti Jain, F Barry Bays, James T Treace, John R Treace, John T Treace, Mark Hair, Richard W Mott, Scot Michael Elder, Sean F Scanlan, Terry W Lubben, and Thomas E Timbie. Learn more on insiders at TMCI.

24.43% of Treace Medical Concepts stock is owned by insiders. Learn more on TMCI's insider holdings.

The following insiders have purchased TMCI shares in the last 24 months: Aaron Berutti ($39,894.50), Deepti Jain ($112,500.00), James T Treace ($905,390.00), John T Treace ($3,294,550.00), and Richard W Mott ($221,571.76).

Insiders have purchased a total of 829,727 TMCI shares in the last 24 months for a total of $4,573,906.26 bought.

The following insiders have sold TMCI shares in the last 24 months: Aaron Berutti ($17,892.53), Daniel E Owens ($283,562.50), F Barry Bays ($33,242,286.35), James T Treace ($3,544,333.84), John T Treace ($50,650.75), Mark Hair ($25,386.40), Richard W Mott ($7,463,462.00), Sean F Scanlan ($1,817,500.00), and Thomas E Timbie ($3,441,945.92).

Insiders have sold a total of 1,970,673 Treace Medical Concepts shares in the last 24 months for a total of $49,887,020.29 sold.

Treace Medical Concepts Key Executives

  • Mr. John T. TreaceMr. John T. Treace (Age 52)
    CEO, Founder & Director
    Compensation: $1.09M
    3 recent trades
  • Mr. Mark L. Hair CPA (Age 54)
    Chief Financial Officer
    Compensation: $599.7k
  • Mr. Aaron J. Berutti (Age 45)
    Senior Vice President of Sales
    Compensation: $484.22k
  • Mr. Terry W. Lubben (Age 59)
    Senior Vice President of Operations
  • Mr. Taylor Erickson
    Chief Information & Security Officer
  • Ms. Julie D. Dewey (Age 63)
    Chief Communications & Investor Relations Officer
  • Mr. Scot M. Elder J.D. (Age 49)
    Chief Legal & Compliance Officer and Corporate Secretary
  • Mr. Nathan Minnich
    Senior Vice President of Marketing
  • Mr. Daniel E. Owens (Age 52)
    Chief Human Resources Officer
  • Dr. Sean F. Scanlan Ph.D. (Age 42)
    Chief Innovation Officer


This page (NASDAQ:TMCI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners